Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q3 2021 · 10-Q
Revenue$15.99M$15.99M+4.6% vs Q3 2020 Net Income-$7.58M-$7.58MN/M vs Q3 2020 EPS Diluted-$0.89-$0.89N/M vs Q3 2020 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Operating Cash Flowderived-$7,075,000N/M Margins · derivedGross margin-2.1%−4.3 pt vs Q3 2020
Operating margin-43.6%+0.2 pt vs Q3 2020
Net margin-47.4%+0.7 pt vs Q3 2020
ended Sep 30, 2021 · filed Nov 15, 2021 · 46 d after period end